Trial of Pimasertib in Hematological Malignancies
Condition(s):Leukemia, Myeloid, Acute; Hematologic NeoplasmsLast Updated:August 21, 2017Terminated
Hide Studies Not Open or Pending
Condition(s):Leukemia, Myeloid, Acute; Hematologic NeoplasmsLast Updated:August 21, 2017Terminated
Condition(s):StrokeLast Updated:November 6, 2020Terminated
Condition(s):Sleep Apnea, Obstructive; Total Knee Arthroplasty; Total Hip ArthroplastyLast Updated:March 9, 2018Withdrawn
Condition(s):Cardiogenic Acute Pulmonary EdemaLast Updated:June 22, 2023Recruiting
Condition(s):Acute Myelogenous Leukemia; Myelodysplastic Syndrome; Acute Lymphoblastic Leukemia; Chronic Myelogenous LeukemiaLast Updated:December 5, 2017Terminated
Condition(s):Esophagus Cancer; Esophagogastric Junction Cancer; Radiotherapy; Complications; ChemoradiationLast Updated:July 21, 2020Completed
Condition(s):Liver DiseaseLast Updated:June 18, 2018Withdrawn
Condition(s):Acute Respiratory Disease; Acute IllnessLast Updated:November 29, 2023Completed
Condition(s):Stroke, IschemicLast Updated:February 24, 2017Completed
Condition(s):Renal Insufficiency, Chronic; ProteinuriaLast Updated:February 22, 2019Unknown status
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.